B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Febuxostat

297 PubMed studies analyzed · 64 RCTs · Evidence Score: 60.5

Research Domains

Febuxostat has been studied across 15 research domains including 🫘 Kidney, ❤️ Cardiovascular, 🔬 Inflammation, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is 🫘 Kidney with 24% of studies addressing this area.

Loading evidence profile...

This evidence profile for Febuxostat is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.